Cervical gestational trophoblastic neoplasia: A rare form of gestational trophoblastic disease

J Cancer Res Ther. 2022 Apr-Jun;18(3):827-830. doi: 10.4103/jcrt.JCRT_959_20.

Abstract

Gestational trophoblastic neoplasia (GTN) is a rare disease and is characterized by an abnormal proliferation of trophoblastic cells of placenta. Since majority of them are chemotherapy sensitive, they are one of the highly curable cancers. However, due to its varied presentation, clinicians still face many challenges in its diagnosis and management. We present a case of 26-year-old woman, P0 + 3 (previous 3 abortions) who presented to us with a history of vaginal bleeding postuterine evacuation after 2 months of incomplete abortion. After clinical, radiological assessment and high human chorionic gonadotropin (hCG) titers, the patient was diagnosed as a case of cervical GTN. Risk assessment by the WHO prognostic scoring system was done and "Low Risk" was assigned to her. She was given total nine cycles of single agent chemotherapy including two consolidation cycles after normalization of hCG titers which patient tolerated well and remained asymptomatic.

Keywords: Cervical gestational trophoblastic neoplasia; gestational trophoblastic neoplasia; per vaginum.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Chorionic Gonadotropin
  • Female
  • Gestational Trophoblastic Disease* / diagnosis
  • Gestational Trophoblastic Disease* / drug therapy
  • Humans
  • Pregnancy
  • Uterine Hemorrhage

Substances

  • Chorionic Gonadotropin